Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gert Luurtsema

Showing results (71-80 of 94) with videos related to

Pageof 10
Sort By:
Epilepsia|May 9, 2007
Pharmacoresistance in epilepsy: a pilot PET study with the P-glycoprotein substrate R-[(11)C]verapamilOliver Langer, Martin Bauer, Alexander Hammers, et al.
EJNMMI Research|August 2, 2019
Optimization of parathyroid <sup>11</sup>C-choline PET protocol for localization of parathyroid adenomas in patients with primary hyperparathyroidismMilou E Noltes, Schelto Kruijff, Walter Noordzij, et al.
Journal of the American Chemical Society|June 28, 2021
Ultrafast Photoclick Reaction for Selective <sup>18</sup>F-Positron Emission Tomography Tracer Synthesis in FlowYouxin Fu, Hugo Helbert, Nadja A Simeth, et al.
Molecular Pharmaceutics|December 14, 2020
Pharmacokinetic Modeling of (<i>R</i>)-[<sup>11</sup>C]verapamil to Measure the P-Glycoprotein Function in Nonhuman PrimatesLara García-Varela, David Vállez García, Takeharu Kakiuchi, et al.
Clinical and Translational Radiation Oncology|July 7, 2023
Effects of proton therapy on regional [<sup>18</sup>F]FDG uptake in non-tumor brain regions of patients treated for head and neck cancerWejdan M Arif, Philip H Elsinga, Roel J H M Steenbakkers, et al.
Journal of Clinical Medicine|July 12, 2025
DSC Perfusion MRI Artefact Reduction Strategies: A Short Overview for Clinicians and Scientific ApplicationsChris W J van der Weijden, Ingomar W Gutmann, Joost F Somsen, et al.
Molecular Pharmaceutics|August 14, 2020
Pharmacokinetic Modeling of [<sup>18</sup>F]MC225 for Quantification of the P-Glycoprotein Function at the Blood-Brain Barrier in Non-Human Primates with PETLara García-Varela, Wejdan M Arif, David Vállez García, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|February 21, 2015
Feasibility of [18F]-RGD for ex vivo imaging of atherosclerosis in detection of αvβ3 integrin expressionReza Golestani, Leila Mirfeizi, Clark J Zeebregts, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 12, 2013
PET imaging of tumor hypoxia using 18F-fluoroazomycin arabinoside in stage III-IV non-small cell lung cancer patientsVikram R Bollineni, Gerald S M A Kerner, Jan Pruim, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 12, 2021
Head-to-head comparison of (R)-[<sup>11</sup>C]verapamil and [<sup>18</sup>F]MC225 in non-human primates, tracers for measuring P-glycoprotein functionLara García-Varela, David Vállez García, Pablo Aguiar, et al.
Pageof 10

Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
Epilepsia|May 9, 2007
Pharmacoresistance in epilepsy: a pilot PET study with the P-glycoprotein substrate R-[(11)C]verapamilOliver Langer, Martin Bauer, Alexander Hammers, et al.
EJNMMI Research|August 2, 2019
Optimization of parathyroid <sup>11</sup>C-choline PET protocol for localization of parathyroid adenomas in patients with primary hyperparathyroidismMilou E Noltes, Schelto Kruijff, Walter Noordzij, et al.
Journal of the American Chemical Society|June 28, 2021
Ultrafast Photoclick Reaction for Selective <sup>18</sup>F-Positron Emission Tomography Tracer Synthesis in FlowYouxin Fu, Hugo Helbert, Nadja A Simeth, et al.
Molecular Pharmaceutics|December 14, 2020
Pharmacokinetic Modeling of (<i>R</i>)-[<sup>11</sup>C]verapamil to Measure the P-Glycoprotein Function in Nonhuman PrimatesLara García-Varela, David Vállez García, Takeharu Kakiuchi, et al.
Clinical and Translational Radiation Oncology|July 7, 2023
Effects of proton therapy on regional [<sup>18</sup>F]FDG uptake in non-tumor brain regions of patients treated for head and neck cancerWejdan M Arif, Philip H Elsinga, Roel J H M Steenbakkers, et al.
Journal of Clinical Medicine|July 12, 2025
DSC Perfusion MRI Artefact Reduction Strategies: A Short Overview for Clinicians and Scientific ApplicationsChris W J van der Weijden, Ingomar W Gutmann, Joost F Somsen, et al.
Molecular Pharmaceutics|August 14, 2020
Pharmacokinetic Modeling of [<sup>18</sup>F]MC225 for Quantification of the P-Glycoprotein Function at the Blood-Brain Barrier in Non-Human Primates with PETLara García-Varela, Wejdan M Arif, David Vállez García, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|February 21, 2015
Feasibility of [18F]-RGD for ex vivo imaging of atherosclerosis in detection of αvβ3 integrin expressionReza Golestani, Leila Mirfeizi, Clark J Zeebregts, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 12, 2013
PET imaging of tumor hypoxia using 18F-fluoroazomycin arabinoside in stage III-IV non-small cell lung cancer patientsVikram R Bollineni, Gerald S M A Kerner, Jan Pruim, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 12, 2021
Head-to-head comparison of (R)-[<sup>11</sup>C]verapamil and [<sup>18</sup>F]MC225 in non-human primates, tracers for measuring P-glycoprotein functionLara García-Varela, David Vállez García, Pablo Aguiar, et al.
Pageof 10